Corrigendum: Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management

…, European Crohn's and Colitis … - … Crohn's and Colitis, 2017 - academic.oup.com
… better tolerated, than prednisone after 4 weeks’ treatment. Oral non-MMX budesonide does
not appear to be efficient in the treatment of UC. Two phase 3 randomised controlled trials (…

[PDF][PDF] Colon specific drug delivery of mesalamine using eudragit S100-coated chitosan microspheres for the treatment of ulcerative colitis

S Badhana, N Garud, A Garud - International Current …, 2013 - pdfs.semanticscholar.org
The purpose of the present study was to prepare, characterize and evaluate the colon-targeted
microspheres of mesalamine for the treatment and management of ulcerative colitis (UC). …

[HTML][HTML] Efficacy and safety of probiotics combined with traditional Chinese medicine for ulcerative colitis: a systematic review and meta-analysis

Y Hu, Z Ye, Y She, L Li, M Wu, K Qin, Y Li… - Frontiers in …, 2022 - frontiersin.org
… indicates that the treatment course of probiotics and TCM application can have a certain
impact on the clinical efficiency. Moreover, due to the lack of long-term treatment process in the …

Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements

, … Gastroenterology Severe Ulcerative Colitis … - Official journal of the …, 2012 - journals.lww.com
… of this study was to provide updated explicit and relevant consensus statements for clinicians
to refer to when managing hospitalized adult patients with acute severe ulcerative colitis (…

Effectiveness and safety of ustekinumab induction therapy for 103 patients with ulcerative colitis: a GETAID multicentre real‐world cohort study

A Amiot, J Filippi, V Abitbol, G Cadiot… - Alimentary …, 2020 - Wiley Online Library
… Those data emphasise the objective improvement of patients with UC treated with
ustekinumab and show that ustekinumab is an efficient therapeutic option in bio-failure patients. …

Cost utility of inflammation-targeted therapy for patients with ulcerative colitis

SD Saini, AK Waljee, PDR Higgins - Clinical Gastroenterology and …, 2012 - Elsevier
… used to treat patients with mild-to-moderate ulcerative colitis (… treatment strategies:
symptom-targeted treatment (treatment … , and inflammation-targeted treatment (mesalamine …

[HTML][HTML] Tacrolimus for the treatment of ulcerative colitis

K Matsuoka, E Saito, T Fujii, K Takenaka… - Intestinal …, 2015 - synapse.koreamed.org
… inhibitor used for the treatment of corticosteroid-refractory ulcerative colitis (UC). Two …
treatment. The oral formula is often used for the treatment of UC, because tacrolimus is efficiently

Embelin lipid nanospheres for enhanced treatment of ulcerative colitis–Preparation, characterization and in vivo evaluation

SS Badamaranahalli, M Kopparam… - European journal of …, 2015 - Elsevier
… Conventional treatment of ulcerative colitis requires the frequent administration of anti-… In
case of IBD treatment, reduction of drug carrier size has been recognized an efficient way to …

[HTML][HTML] “Two-birds-one-stone” colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis

J Zhang, A Ou, X Tang, R Wang, Y Fan, Y Fang… - Journal of …, 2022 - Springer
… two formidable challenges for ulcerative colitis treatment. It … the intestinal epithelial cell
uptake efficiency and improved the … is promising for ulcerative colitis treatment and to address …

Improving drug utilization platform with injectable mucoadhesive hydrogel for treating ulcerative colitis

L Zhao, F Wang, Z Cai, Q Zhou, B Chen… - Chemical Engineering …, 2021 - Elsevier
… release of active molecules would be prevented, thereby improving the drug delivery
efficiency. Such mechanical properties play an important role in DSS-induced UC treatment. …